A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study)

NCT02327416 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: Y peginterferon alfa-2b
DRUG: Granulocyte-macrophage colony stimulating factor
DRUG: Entecavir and or adefovir dipivoxil

Sponsor

Tongji Hospital

Collaborators

[object Object]